CN103041069A - Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof - Google Patents
Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof Download PDFInfo
- Publication number
- CN103041069A CN103041069A CN2011104088963A CN201110408896A CN103041069A CN 103041069 A CN103041069 A CN 103041069A CN 2011104088963 A CN2011104088963 A CN 2011104088963A CN 201110408896 A CN201110408896 A CN 201110408896A CN 103041069 A CN103041069 A CN 103041069A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hyperlipidemia
- obesity
- pure chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 16
- 208000008589 Obesity Diseases 0.000 title claims abstract description 14
- 235000020824 obesity Nutrition 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 9
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 9
- 229940082787 spirulina Drugs 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 18
- 241000756943 Codonopsis Species 0.000 claims description 8
- 241000222640 Polyporus Species 0.000 claims description 8
- 241000207929 Scutellaria Species 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 238000004163 cytometry Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110408896.3A CN103041069B (en) | 2011-12-11 | 2011-12-11 | Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110408896.3A CN103041069B (en) | 2011-12-11 | 2011-12-11 | Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041069A true CN103041069A (en) | 2013-04-17 |
CN103041069B CN103041069B (en) | 2014-12-17 |
Family
ID=48054080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110408896.3A Active CN103041069B (en) | 2011-12-11 | 2011-12-11 | Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041069B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446571A (en) * | 2013-09-22 | 2013-12-18 | 曹丽荣 | Drug for dispelling dampness and losing weight |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288498A (en) * | 2015-12-02 | 2016-02-03 | 青岛华之草医药科技有限公司 | Method for preparing folium artemisiae argyi-contained traditional Chinese medicine preparation capable of treating obesity |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
-
2011
- 2011-12-11 CN CN201110408896.3A patent/CN103041069B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446571A (en) * | 2013-09-22 | 2013-12-18 | 曹丽荣 | Drug for dispelling dampness and losing weight |
CN103446571B (en) * | 2013-09-22 | 2015-06-03 | 曹丽荣 | Drug for dispelling dampness and losing weight |
Also Published As
Publication number | Publication date |
---|---|
CN103041069B (en) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190038699A1 (en) | Seven-star tea without excipient and method of preparing the same | |
CN105105116A (en) | Health food with effects of relieving physical fatigue and enhancing immunity and preparation method of health food | |
CN103341052A (en) | Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof | |
CN1054370A (en) | A kind of manufacture method of kidney-tonifying health-care medicament | |
CN103041069B (en) | Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof | |
CN104288344B (en) | Application of Pu' er tea extract in preparation of medicine or food for regulating intestinal flora and relaxing bowels | |
CN100345566C (en) | Medicine composition used for reducing weight, prepn. method and use thereof | |
CN101524441A (en) | Chinese medicinal composition for lipid-lowering and weight-losing and preparation method thereof | |
CN102640921A (en) | Dietary anti-aging tea granules | |
CN102640825B (en) | Lipid-lowering tea for regulating blood lipid | |
CN101940696A (en) | Method for preparing Chinese medicinal compound Zengshengping | |
CN108077702A (en) | Pueraria lobata radix polygonati officinalis solid beverage and preparation method | |
CN106309729B (en) | A kind of Chinese medicine composition adjusting chronic hepatitis immune function | |
CN107281386B (en) | Method for preparing medicine for treating hypertension by using dendrobium officinale and radish seeds and application | |
CN104069144A (en) | Three formula granules for forming Shengmai powder and preparation method thereof | |
CN108404088B (en) | Traditional Chinese medicine for treating type II diabetes and preparation method thereof | |
CN103285277A (en) | Umbilical sticking agent for reducing weight and preparation method thereof | |
CN102669344A (en) | Food senescence delaying tea granule | |
CN107582866B (en) | Application method of dendrobium officinale and amlodipine in preparation of medicine for treating hypertension | |
CN104707106A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method thereof | |
CN105125639A (en) | Traditional Chinese medicine composition for preventing and treating mastitis of dairy cattle | |
CN103356924A (en) | Drug for preventing and treating fatty liver and preparation method thereof | |
CN102614271A (en) | Chinese medicine for treating diabetic dyslipidemia | |
CN102078562B (en) | Chinese medicinal oral liquid for treating children metabolic syndrome and preparation method thereof | |
CN102366537A (en) | Traditional Chinese medicine preparation for treating cough caused by lung dryness and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Tang Yonghong Inventor after: Song Zhe Inventor after: Song Yuanzhi Inventor before: Song Yuanzhi Inventor before: Song Zhe Inventor before: Tang Yonghong |
|
CB03 | Change of inventor or designer information | ||
CP03 | Change of name, title or address |
Address after: Room 1, No. 710077 B601 gazelle Valley in Shaanxi province high tech Zone of Xi'an Jinye Road No. 69 business development park C District Patentee after: XI'AN TAIKOMED MEDICAL TECHNOLOGY Co.,Ltd. Address before: 710077, 1-10502B, No. 2, No. 85, No. 3 Road, Xi'an hi tech Zone, Shaanxi Patentee before: Xi'an Takomed Pharmaceutical Technology Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240613 Address after: Room 1311, Building C, Chengfang Creation Century Plaza, No. 120 Yongwan Road, Xiuying District, Haikou City, Hainan Province, 570100 Patentee after: Jiayuan Pharmaceutical Investment (Hainan) Co.,Ltd. Country or region after: China Patentee after: Suzhou Guochen Enterprise Management Partnership (Limited Partnership) Address before: Room B601, gazelle Valley, No.1, Zone C, venture R & D Park, 69 Jinye Road, high tech Zone, Xi'an City, Shaanxi Province, 710077 Patentee before: XI'AN TAIKOMED MEDICAL TECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |